AGDA KARINA B. ETEROVIC

Concepts (344)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
High-Throughput Nucleotide Sequencing
11
2024
2357
0.840
Why?
Mutation
23
2021
15911
0.640
Why?
Medulloblastoma
3
2018
572
0.540
Why?
Cerebellar Neoplasms
2
2018
478
0.530
Why?
Skin Neoplasms
7
2019
4889
0.480
Why?
Biomarkers, Tumor
9
2021
10701
0.450
Why?
DNA, Neoplasm
3
2017
1958
0.450
Why?
Brain Neoplasms
7
2019
4957
0.440
Why?
Glioblastoma
6
2019
1775
0.440
Why?
Hymenoptera
2
2009
9
0.420
Why?
Neuroblastoma
1
2018
705
0.410
Why?
Circulating Tumor DNA
3
2021
275
0.400
Why?
RNA Editing
3
2017
97
0.380
Why?
DNA Copy Number Variations
6
2021
1556
0.370
Why?
Neoplasms, Second Primary
1
2018
1387
0.340
Why?
Nesting Behavior
1
2009
14
0.340
Why?
Trehalase
3
2005
5
0.290
Why?
Inosine
3
2017
42
0.290
Why?
Sequence Analysis, DNA
4
2021
2573
0.280
Why?
Neoplasms
10
2021
15909
0.280
Why?
Bone Neoplasms
1
2019
2664
0.270
Why?
Genomics
6
2021
2835
0.270
Why?
Drug Resistance, Neoplasm
6
2017
5403
0.270
Why?
Gene Expression Profiling
7
2020
5141
0.270
Why?
Phthalazines
2
2018
262
0.260
Why?
Gene Expression Regulation, Neoplastic
8
2019
9036
0.250
Why?
Adenosine
3
2017
296
0.250
Why?
Poly(ADP-ribose) Polymerase Inhibitors
3
2018
518
0.240
Why?
Breast Neoplasms
6
2019
16204
0.230
Why?
Benchmarking
1
2024
275
0.200
Why?
Precision Medicine
3
2021
1207
0.200
Why?
Protein Kinase Inhibitors
4
2019
4960
0.200
Why?
Retinoblastoma Binding Proteins
2
2018
66
0.200
Why?
RNA Polymerase II
1
2010
184
0.170
Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2009
3603
0.170
Why?
Methyltransferases
1
2010
152
0.160
Why?
Mucor
2
2000
18
0.160
Why?
Humans
45
2024
270631
0.160
Why?
Melanoma
4
2018
5594
0.160
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2018
16664
0.160
Why?
Penile Neoplasms
1
2021
183
0.160
Why?
Patient Participation
1
2012
453
0.160
Why?
Heterocyclic Compounds, 3-Ring
1
2019
153
0.150
Why?
Female
30
2020
148865
0.150
Why?
Prognosis
7
2021
22473
0.150
Why?
Lysine
1
2010
426
0.150
Why?
Nevus, Epithelioid and Spindle Cell
1
2018
47
0.150
Why?
Autophagy-Related Proteins
1
2018
55
0.150
Why?
Neoplasms, Neuroepithelial
1
2008
30
0.150
Why?
Oncogenes
1
2021
700
0.150
Why?
RNA, Neoplasm
2
2017
806
0.150
Why?
Middle Aged
23
2021
90294
0.150
Why?
Hemangioma
1
2019
157
0.140
Why?
Poly (ADP-Ribose) Polymerase-1
1
2018
162
0.140
Why?
Antineoplastic Agents
7
2018
14616
0.140
Why?
RNA, Messenger
3
2017
6397
0.140
Why?
Class I Phosphatidylinositol 3-Kinases
1
2019
529
0.140
Why?
Computational Biology
5
2024
1293
0.140
Why?
Reproduction
2
2009
278
0.140
Why?
Adult
20
2021
81946
0.140
Why?
Ubiquitin-Protein Ligases
2
2018
874
0.140
Why?
Proto-Oncogene Proteins c-kit
1
2018
484
0.140
Why?
Oligonucleotide Array Sequence Analysis
2
2013
2474
0.130
Why?
Drug Resistance, Multiple
1
2007
221
0.130
Why?
Laboratories
1
2017
132
0.130
Why?
Aged, 80 and over
11
2021
30994
0.130
Why?
Carcinoma, Merkel Cell
1
2018
172
0.130
Why?
Histone Deacetylases
1
2008
364
0.130
Why?
Heterografts
2
2015
739
0.130
Why?
Eye Neoplasms
1
2018
257
0.130
Why?
Neoplasm Recurrence, Local
5
2019
10383
0.130
Why?
Cell Line, Tumor
11
2019
14833
0.130
Why?
Astrocytoma
1
2008
326
0.130
Why?
Cystadenocarcinoma, Serous
1
2020
496
0.130
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2018
396
0.130
Why?
Aged
17
2021
73338
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2008
695
0.130
Why?
BRCA2 Protein
1
2017
379
0.130
Why?
DNA Mutational Analysis
3
2019
2357
0.120
Why?
Decision Making
1
2012
1249
0.120
Why?
Mitogen-Activated Protein Kinase Kinases
1
2017
383
0.120
Why?
Genetic Testing
2
2021
1697
0.120
Why?
Cadherins
1
2008
657
0.120
Why?
Leukocytes, Mononuclear
1
2017
714
0.120
Why?
Genome, Human
3
2019
1885
0.120
Why?
Research
1
2017
427
0.120
Why?
Intracellular Signaling Peptides and Proteins
1
2010
1280
0.120
Why?
Lung Neoplasms
4
2020
12024
0.120
Why?
Genetic Heterogeneity
1
2016
326
0.120
Why?
Benzoxazoles
1
2014
40
0.120
Why?
BRCA1 Protein
1
2017
525
0.120
Why?
Protein Array Analysis
1
2017
503
0.120
Why?
Antibodies, Monoclonal
3
2016
4480
0.120
Why?
Genes, ras
1
2017
679
0.120
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2018
627
0.110
Why?
Cerebellum
1
2018
471
0.110
Why?
Drugs, Investigational
1
2015
130
0.110
Why?
Repetitive Sequences, Nucleic Acid
1
2015
471
0.110
Why?
Fungi
1
2005
147
0.110
Why?
Mutation, Missense
1
2019
1193
0.110
Why?
Histones
1
2010
1512
0.110
Why?
Genes, Tumor Suppressor
1
2017
1126
0.110
Why?
Epigenesis, Genetic
2
2018
1442
0.110
Why?
Vascular Endothelial Growth Factor A
1
2009
1579
0.110
Why?
Trehalose
2
2000
25
0.110
Why?
Cell Wall
2
2000
51
0.110
Why?
Uveal Neoplasms
1
2015
194
0.100
Why?
Male
22
2021
128316
0.100
Why?
Medical Oncology
1
2021
1463
0.100
Why?
Philadelphia Chromosome
1
2016
852
0.100
Why?
Central Nervous System Neoplasms
1
2007
551
0.100
Why?
Proto-Oncogene Proteins c-akt
1
2019
2073
0.100
Why?
Polymorphism, Single Nucleotide
3
2024
4646
0.100
Why?
Proto-Oncogene Proteins c-met
1
2015
427
0.100
Why?
Nuclear Proteins
2
2017
3438
0.100
Why?
TOR Serine-Threonine Kinases
2
2017
1564
0.100
Why?
Gallbladder Neoplasms
1
2013
244
0.100
Why?
Neoplastic Stem Cells
1
2019
1457
0.090
Why?
Brain
3
2008
4212
0.090
Why?
Sensitivity and Specificity
2
2021
5171
0.090
Why?
Neoplasm Grading
3
2021
1822
0.090
Why?
Glioma
2
2019
1977
0.090
Why?
ras Proteins
1
2015
804
0.090
Why?
Cell Transformation, Neoplastic
1
2019
2453
0.090
Why?
Xenograft Model Antitumor Assays
5
2017
3918
0.090
Why?
Immunohistochemistry
5
2019
7663
0.090
Why?
Infant
4
2018
13982
0.090
Why?
Papillomavirus Infections
1
2018
999
0.090
Why?
Lymphatic Metastasis
1
2019
4963
0.090
Why?
Decision Support Techniques
1
2015
601
0.090
Why?
Gene Expression
1
2008
3641
0.090
Why?
T-Lymphocytes
2
2020
3943
0.090
Why?
Carcinoma, Non-Small-Cell Lung
2
2020
5566
0.090
Why?
Tumor Suppressor Protein p53
2
2018
3656
0.080
Why?
Chemoradiotherapy
1
2018
2027
0.080
Why?
Piperazines
1
2018
2145
0.080
Why?
Genetic Variation
1
2017
2165
0.080
Why?
Mice, Nude
4
2015
4329
0.080
Why?
Neoplasm Proteins
2
2017
3344
0.080
Why?
Animals
12
2017
62031
0.070
Why?
Proto-Oncogene Proteins B-raf
1
2015
1335
0.070
Why?
Gene Regulatory Networks
2
2013
680
0.070
Why?
DNA Methylation
1
2018
2766
0.070
Why?
Triple Negative Breast Neoplasms
1
2017
1388
0.070
Why?
Molecular Targeted Therapy
4
2021
2399
0.070
Why?
Case-Control Studies
3
2021
6238
0.070
Why?
Ovarian Neoplasms
2
2020
4790
0.070
Why?
MicroRNAs
2
2017
2886
0.070
Why?
Pyrimidines
2
2018
3666
0.070
Why?
Proto-Oncogene Proteins
1
2015
2618
0.060
Why?
Reproducibility of Results
3
2021
6191
0.060
Why?
Tumor Burden
3
2016
2033
0.060
Why?
Neoplasm Invasiveness
3
2017
4048
0.060
Why?
Epithelial-Mesenchymal Transition
2
2017
1002
0.060
Why?
Follow-Up Studies
1
2019
15204
0.060
Why?
Prospective Studies
1
2019
13412
0.060
Why?
Head and Neck Neoplasms
2
2018
4140
0.060
Why?
Kaplan-Meier Estimate
3
2019
6253
0.060
Why?
Neoplasm Staging
4
2021
14009
0.060
Why?
INDEL Mutation
1
2024
114
0.060
Why?
Magnetic Resonance Imaging
2
2018
7893
0.060
Why?
Neoplasm Metastasis
3
2019
5309
0.050
Why?
Gene Frequency
2
2017
1247
0.050
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2016
2902
0.050
Why?
Survival Analysis
3
2020
9290
0.050
Why?
Immunotherapy
1
2016
3553
0.050
Why?
Mice
7
2017
35586
0.050
Why?
Quality Control
1
2024
460
0.050
Why?
Adolescent
6
2018
32719
0.050
Why?
Promoter Regions, Genetic
2
2018
3214
0.050
Why?
Enzyme Stability
2
2005
110
0.050
Why?
Edetic Acid
2
2005
76
0.050
Why?
Bevacizumab
2
2010
966
0.050
Why?
Limit of Detection
1
2021
85
0.050
Why?
Butyrate Response Factor 1
1
2010
6
0.050
Why?
Child, Preschool
4
2018
17028
0.050
Why?
Disease-Free Survival
3
2018
10258
0.050
Why?
Germ-Line Mutation
2
2017
1101
0.050
Why?
Mice, SCID
2
2015
1825
0.050
Why?
Hydrogen-Ion Concentration
2
2005
606
0.050
Why?
Cohort Studies
3
2018
9471
0.040
Why?
Bone Morphogenetic Protein 4
1
2010
103
0.040
Why?
Temperature
2
2005
538
0.040
Why?
Carcinoma, Squamous Cell
1
2016
5588
0.040
Why?
Matrix Metalloproteinase 12
1
2009
18
0.040
Why?
ErbB Receptors
2
2020
2376
0.040
Why?
Chemokine CXCL9
1
2009
24
0.040
Why?
Cell Movement
2
2015
2471
0.040
Why?
Databases, Genetic
1
2013
757
0.040
Why?
Ribonuclease, Pancreatic
1
2009
59
0.040
Why?
Tissue Embedding
1
2019
28
0.040
Why?
Genetic Predisposition to Disease
3
2019
5775
0.040
Why?
GTP-Binding Protein alpha Subunits, Gq-G11
1
2019
51
0.040
Why?
Cell Proliferation
3
2018
7235
0.040
Why?
Boston
1
2019
133
0.040
Why?
Sampling Studies
1
2019
170
0.040
Why?
Methylation
1
2010
624
0.040
Why?
Back
1
2018
49
0.040
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2009
121
0.040
Why?
Molecular Diagnostic Techniques
1
2021
334
0.040
Why?
Epidermal Cyst
1
2018
47
0.040
Why?
Lymphocyte Count
1
2020
485
0.040
Why?
Clone Cells
1
2020
591
0.040
Why?
Neoplasms, Adnexal and Skin Appendage
1
2018
65
0.040
Why?
Molecular Sequence Annotation
1
2019
198
0.040
Why?
Disease Susceptibility
1
2021
550
0.040
Why?
Acrylonitrile
1
2017
9
0.040
Why?
Adenocarcinoma
1
2016
7913
0.040
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2009
266
0.040
Why?
Gene Knockdown Techniques
1
2010
1077
0.040
Why?
Leukemia Inhibitory Factor Receptor alpha Subunit
1
2017
21
0.040
Why?
Zinc Finger E-box Binding Homeobox 2
1
2017
43
0.040
Why?
Histone-Lysine N-Methyltransferase
1
2010
460
0.040
Why?
Forkhead Box Protein O3
1
2017
108
0.040
Why?
Drug Monitoring
1
2019
352
0.040
Why?
Models, Statistical
1
2013
1185
0.030
Why?
Zinc Finger E-box-Binding Homeobox 1
1
2017
167
0.030
Why?
Metabolomics
1
2020
504
0.030
Why?
Radiation-Sensitizing Agents
1
2008
366
0.030
Why?
Child
4
2018
30517
0.030
Why?
Homologous Recombination
1
2017
187
0.030
Why?
Calibration
1
2007
347
0.030
Why?
Enzyme-Linked Immunosorbent Assay
1
2009
1525
0.030
Why?
Workflow
1
2017
277
0.030
Why?
Aniline Compounds
1
2017
206
0.030
Why?
Receptors, Cytokine
1
2016
179
0.030
Why?
Disease Progression
2
2019
6853
0.030
Why?
Receptors, Notch
1
2018
372
0.030
Why?
Algorithms
2
2017
3900
0.030
Why?
Poly(ADP-ribose) Polymerases
1
2017
322
0.030
Why?
Pronase
1
2005
8
0.030
Why?
Papillomaviridae
1
2018
636
0.030
Why?
Disease Management
1
2021
1089
0.030
Why?
Oxygenases
1
2014
26
0.030
Why?
Sequence Analysis, RNA
1
2018
676
0.030
Why?
Lymphocyte Activation
1
2020
1723
0.030
Why?
mRNA Cleavage and Polyadenylation Factors
1
2015
57
0.030
Why?
Adenosine Deaminase
1
2015
113
0.030
Why?
Dasatinib
1
2018
881
0.030
Why?
Allosteric Regulation
1
2014
71
0.030
Why?
Mechanistic Target of Rapamycin Complex 2
1
2014
69
0.030
Why?
DNA Primers
1
2007
1496
0.030
Why?
Isocitrate Dehydrogenase
1
2019
522
0.030
Why?
Loss of Heterozygosity
1
2016
622
0.030
Why?
Mutagenesis, Insertional
1
2015
219
0.030
Why?
Imatinib Mesylate
1
2018
1690
0.030
Why?
Cyclic AMP Response Element-Binding Protein
1
2015
195
0.030
Why?
Tongue Neoplasms
1
2016
253
0.030
Why?
Drug Approval
1
2015
174
0.030
Why?
Luciferases
1
2015
460
0.030
Why?
Cancer Care Facilities
1
2018
907
0.030
Why?
Gene Expression Regulation, Leukemic
1
2016
581
0.030
Why?
Drug Synergism
1
2017
1359
0.030
Why?
Gene Fusion
1
2015
214
0.030
Why?
United States Food and Drug Administration
1
2015
324
0.030
Why?
Antibodies, Monoclonal, Humanized
2
2010
3408
0.030
Why?
Sex Factors
1
2019
2184
0.030
Why?
Catalytic Domain
1
2014
305
0.030
Why?
Tissue Fixation
1
2013
137
0.030
Why?
Formaldehyde
1
2013
116
0.030
Why?
Blotting, Western
1
2009
3586
0.030
Why?
Mechanistic Target of Rapamycin Complex 1
1
2014
274
0.030
Why?
Paraffin Embedding
1
2013
223
0.030
Why?
Microsatellite Repeats
1
2015
628
0.030
Why?
Skin
1
2018
1273
0.030
Why?
In Situ Hybridization, Fluorescence
1
2018
2308
0.030
Why?
Adenosine Triphosphate
1
2005
587
0.030
Why?
MAP Kinase Signaling System
1
2017
885
0.030
Why?
Treatment Outcome
3
2019
33722
0.030
Why?
Glucose
2
2000
1220
0.030
Why?
Genes, Reporter
1
2015
820
0.030
Why?
CTLA-4 Antigen
1
2016
678
0.030
Why?
Multiprotein Complexes
1
2014
385
0.030
Why?
Laryngeal Neoplasms
1
2016
529
0.030
Why?
Drug Design
1
2014
371
0.030
Why?
Young Adult
3
2017
22201
0.020
Why?
Angiogenesis Inhibitors
1
2009
1266
0.020
Why?
Janus Kinase 2
1
2016
754
0.020
Why?
Transcription Factors
2
2017
5439
0.020
Why?
Neoplasm Transplantation
1
2015
1554
0.020
Why?
Ipilimumab
1
2016
759
0.020
Why?
Feasibility Studies
1
2017
2363
0.020
Why?
Exome
1
2016
1248
0.020
Why?
Dose-Response Relationship, Drug
1
2009
5070
0.020
Why?
Practice Guidelines as Topic
1
2021
2394
0.020
Why?
Time Factors
2
2015
13017
0.020
Why?
Mouth Neoplasms
1
2016
734
0.020
Why?
Mice, Inbred BALB C
1
2015
2456
0.020
Why?
Tumor Cells, Cultured
1
2018
5759
0.020
Why?
Anaerobiosis
1
2000
21
0.020
Why?
Sirolimus
1
2014
831
0.020
Why?
DNA Repair
1
2018
1910
0.020
Why?
Gene Deletion
1
2015
1473
0.020
Why?
Evidence-Based Medicine
1
2015
1034
0.020
Why?
Research Design
1
2017
1569
0.020
Why?
Enzyme Induction
1
2000
259
0.020
Why?
Transfection
1
2015
3118
0.020
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2010
86
0.020
Why?
Models, Theoretical
1
2014
798
0.020
Why?
Survival Rate
1
2013
12518
0.020
Why?
Proteomics
1
2017
1426
0.020
Why?
Age Factors
1
2019
5464
0.020
Why?
Gene Expression Regulation
1
2010
4134
0.020
Why?
Cell Survival
1
2015
3062
0.020
Why?
DNA Damage
1
2017
1988
0.020
Why?
RNA-Binding Proteins
1
2015
1017
0.020
Why?
Culture Media
1
2000
343
0.020
Why?
Matrix Metalloproteinase 2
1
2010
258
0.020
Why?
Lung
1
2020
3299
0.020
Why?
Incidence
1
2019
5821
0.020
Why?
Computer Simulation
1
2014
1570
0.020
Why?
Base Sequence
1
2015
5437
0.020
Why?
Proto-Oncogene Proteins p21(ras)
1
2015
1401
0.020
Why?
Receptors, Estrogen
1
2015
2171
0.020
Why?
Proportional Hazards Models
1
2016
5100
0.020
Why?
Transcriptome
1
2016
1954
0.020
Why?
Biomarkers
1
2019
5060
0.020
Why?
Molecular Sequence Data
1
2015
6686
0.020
Why?
Texas
1
2018
6436
0.020
Why?
Polymerase Chain Reaction
1
2014
3478
0.020
Why?
Extracellular Space
1
1997
148
0.020
Why?
Chemotherapy, Adjuvant
1
2015
4000
0.020
Why?
Alleles
1
2014
2590
0.020
Why?
Social Behavior
1
2009
310
0.020
Why?
Cytosol
1
1997
267
0.020
Why?
Immunotherapy, Adoptive
1
2016
1840
0.020
Why?
Cyclic AMP
1
1997
378
0.020
Why?
Risk Assessment
1
2019
6766
0.020
Why?
Predictive Value of Tests
1
2015
4962
0.020
Why?
Image Enhancement
1
2010
553
0.020
Why?
Behavior, Animal
1
2009
750
0.020
Why?
Receptor, ErbB-2
1
2015
2651
0.020
Why?
Disease Models, Animal
1
2017
7383
0.010
Why?
Enzyme Activation
1
1997
1811
0.010
Why?
DNA-Binding Proteins
1
2017
5001
0.010
Why?
Apoptosis
1
2018
7752
0.010
Why?
Phenotype
1
2015
6504
0.010
Why?
Neoadjuvant Therapy
1
2015
5231
0.010
Why?
Calcium
1
1997
1588
0.010
Why?
Risk Factors
1
2016
17875
0.010
Why?
Phosphorylation
1
1997
4945
0.010
Why?
United States
1
2015
15834
0.010
Why?
Signal Transduction
1
2014
12098
0.010
Why?
Retrospective Studies
1
2018
39811
0.010
Why?
ETEROVIC's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (344)
Explore
_
Co-Authors (138)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_